1. Home
  2. PAYS vs PROF Comparison

PAYS vs PROF Comparison

Compare PAYS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysign Inc.

PAYS

Paysign Inc.

HOLD

Current Price

$6.52

Market Cap

293.4M

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.50

Market Cap

238.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYS
PROF
Founded
2001
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.4M
238.1M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
PAYS
PROF
Price
$6.52
$6.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$9.42
$12.00
AVG Volume (30 Days)
802.5K
92.5K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
85.71
25.89
EPS
0.13
1.41
Revenue
$24,120,434.00
$16,098,000.00
Revenue This Year
$33.83
$92.40
Revenue Next Year
$14.89
$64.10
P/E Ratio
$50.65
$4.74
Revenue Growth
N/A
50.73
52 Week Low
$2.28
$3.92
52 Week High
$8.88
$8.95

Technical Indicators

Market Signals
Indicator
PAYS
PROF
Relative Strength Index (RSI) 69.26 49.99
Support Level $5.09 $5.75
Resistance Level $8.88 $7.07
Average True Range (ATR) 0.35 0.43
MACD -0.01 0.01
Stochastic Oscillator 94.04 49.28

Price Performance

Historical Comparison
PAYS
PROF

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: